狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司
            中級(jí)會(huì)員 | 第10年

            15012456311

            當(dāng)前位置:> 供求商機(jī)> 利格列汀雜質(zhì) Linagliptin

            利格列汀雜質(zhì) Linagliptin
            • 利格列汀雜質(zhì) Linagliptin

            貨物所在地:廣東深圳市

            更新時(shí)間:2024-10-10 21:00:07

            瀏覽次數(shù):193

            在線詢(xún)價(jià)收藏商機(jī)

            ( 聯(lián)系我們,請(qǐng)說(shuō)明是在 化工儀器網(wǎng) 上看到的信息,謝謝?。?/p>

            利格列汀雜質(zhì) Linagliptin
            圖譜證書(shū)齊全,純度高,質(zhì)量保證,*,可接定制。
            25mg/50mg/100mg等多種規(guī)格可選。

            利格列汀雜質(zhì) Linagliptin?      產(chǎn)品介紹:

            隨貨提供:所有雜質(zhì)對(duì)照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書(shū)。

            雜質(zhì)定制服務(wù):我司有專(zhuān)業(yè)研發(fā)團(tuán)隊(duì),可提供雜質(zhì)定制服務(wù),以zui大可能的滿(mǎn)足您對(duì)雜質(zhì)對(duì)照品的選購(gòu)需求。

             

            利格列汀雜質(zhì) Linagliptin?        產(chǎn)品信息請(qǐng):

            何          :phastandards

            國(guó)產(chǎn)進(jìn)口品牌皆有銷(xiāo)售,部分雜質(zhì)長(zhǎng)期備有庫(kù)存,可快速發(fā)貨。

             

                   雜質(zhì)列表:

            中文名稱(chēng)

            英文名稱(chēng)

            利格列汀標(biāo)準(zhǔn)品

            Linagliptin

            利格列汀雜質(zhì)1

            2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide

            利格列汀雜質(zhì)2

            (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

            利格列汀雜質(zhì)3

            N-Phthalimide-linagliptin

            利格列汀雜質(zhì)4

            N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide

            利格列汀雜質(zhì)5

            (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid

            利格列汀雜質(zhì)6

            8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)

            利格列汀雜質(zhì)7

            Linagliptin Diene Impurity

            利格列汀雜質(zhì)8

            Linagliptin Acetamide

            利格列汀雜質(zhì)9

            (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

            利格列汀雜質(zhì)10

            (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione

            利格列汀雜質(zhì)11

            8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

            利格列汀雜質(zhì)12

            (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

            利格列汀雜質(zhì)13

            (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

            利格列汀雜質(zhì)14

            (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione

            利格列汀雜質(zhì)15

            (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide

            利格列汀雜質(zhì)16

            (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

            利格列汀雜質(zhì)17

            (S)-Linagliptin

            利格列汀雜質(zhì)18

            N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide

            利格列汀雜質(zhì)19

            (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

            利格列汀雜質(zhì)20

            (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide

            利格列汀雜質(zhì)21

            (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

            利格列汀雜質(zhì)22

            (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione

            利格列汀雜質(zhì)23

            (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

            利格列汀雜質(zhì)24

            (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

            利格列汀雜質(zhì)25

            (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

                   深圳遠(yuǎn)揚(yáng)化學(xué)除國(guó)產(chǎn)雜質(zhì)對(duì)照品外,代理有加拿大TLC雜質(zhì)對(duì)照品,TRC雜質(zhì)對(duì)照品,MC雜質(zhì)對(duì)照品,英國(guó)NIBSC標(biāo)準(zhǔn)品,美國(guó)CIL同位素標(biāo)準(zhǔn)品,NIST標(biāo)準(zhǔn)物質(zhì),歐洲標(biāo)準(zhǔn)局IRMM標(biāo)準(zhǔn)物質(zhì)等,原廠訂貨,質(zhì)量保證。

             

                  部分NIBSC標(biāo)準(zhǔn)品產(chǎn)品列表:

            03/104-105

            HTLV-90 (antibody) Monitor Sample

            13/223

            Influenza Antigen B/Massachusetts/02/2101 (Egg derived)

            13/184

            C-Peptide, Human. 39st International Standard.

            10/111

            Reteplase Reference Material

            13/176

            C-Peptide, Human. 31st International Standard.

            13/264

            Polio Anti Sabin type 47 (inactivated) Serum

            13/239

            Polio Anti Sabin type 22 (inactivated) Serum

            13/265

            Polio Anti Sabin type 48 (inactivated) Serum

            95/659

            Interleukin-120 (Human, rDNA derived)

            13/189

            Influenza Antigen B/Massachusetts/02/2067 (Egg derived)

            01/447

            Meningococcal serogroup W polysaccharide

            13/151

            C-Peptide, Human. 6st International Standard.

            13/150

            C-Peptide, Human. 5st International Standard.

            10/134

            Reteplase Reference Material

            13/146

            C-Peptide, Human. 1st International Standard.

            95/616

            Interleukin-77 (Human, rDNA derived)

            07/359

            BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent)

            13/243

            C-Peptide, Human. 98st International Standard.

            07/290

            BCG Vaccine of Russian BCG-I sub-strain(17st WHO Reference Reagent)

            03/104-032

            HTLV-17 (antibody) Monitor Sample

            03/104-039

            HTLV-24 (antibody) Monitor Sample

            95/563

            Interleukin-24 (Human, rDNA derived)

            13/164

            Influenza Antigen B/Massachusetts/02/2042 (Egg derived)

            12/B623-068

            QCRFLUAH1N1QC1-Influenza AH1N1 QC66

            07/292

            BCG Vaccine of Russian BCG-I sub-strain(19st WHO Reference Reagent)

            會(huì)員登錄

            ×

            請(qǐng)輸入賬號(hào)

            請(qǐng)輸入密碼

            =

            請(qǐng)輸驗(yàn)證碼

            收藏該商鋪

            X
            該信息已收藏!
            標(biāo)簽:
            保存成功

            (空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

            常用:

            提示

            X
            您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
            撥打電話
            在線留言